• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿育吠陀医学与现代医学的界面:对治疗骨关节炎和类风湿关节炎的阿育吠陀药物研究的批判性评估。

Ayurveda-modern medicine interface: A critical appraisal of studies of Ayurvedic medicines to treat osteoarthritis and rheumatoid arthritis.

作者信息

Chopra Arvind, Saluja Manjit, Tillu Girish

机构信息

Center for Rheumatic Diseases, Pune, India.

出版信息

J Ayurveda Integr Med. 2010 Jul;1(3):190-8. doi: 10.4103/0975-9476.72620.

DOI:10.4103/0975-9476.72620
PMID:21547047
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3087360/
Abstract

The potential of Ayurvedic philosophy and medicines needs to be recognized and converted into real life treatment paradigm. This article describes a comprehensive therapeutic approach used in Ayurveda and modern medicine to treat arthritis. We present concise summary of various controlled drug trials carried out by us to validate standardized Ayurvedic drugs using modern medicine protocol to treat Rheumatoid Arthritis and Osteoarthritis knees. Several of the latter are published. The trials consistently demonstrate excellent safety of Ayurvedic medicines but often fail to unequivocally show superior efficacy. Some key findings of a recently unpublished trial in OA knees are also presented to show equivalence between Ayurvedic medicine and celecoxib and glucosamine, and we speculate that equivalence trials may be a way forward. The data from the trials also supports the Ayurvedic 'Rasayana' concept of immune-modulation and healing. We need to interpret logic of Ayurveda when, adopting modern science tools in drug development and validation and much research is required. Validation of Ayurvedic medicines using the latter approach may lead to an evidence based Ayurveda - Modern Medicine interface. Also, in pursuit of finding better treatment solutions, we ought to step beyond the realm of only drugs and attempt validation of comprehensive specific treatment package as per classical Ayurveda. Finally, validation of a combined (Ayurveda and modern medicine) therapeutic approach with superior efficacy and safety is likely to be a major leap in overcoming some of the current frustrations to treat difficult disorders like arthritis using only modern medicines.

摘要

阿育吠陀哲学和药物的潜力需要得到认可,并转化为现实生活中的治疗模式。本文描述了阿育吠陀医学和现代医学用于治疗关节炎的综合治疗方法。我们简要总结了我们进行的各种对照药物试验,这些试验使用现代医学方案来验证标准化的阿育吠陀药物治疗类风湿性关节炎和膝骨关节炎的效果。其中一些试验已经发表。这些试验一致证明了阿育吠陀药物具有出色的安全性,但往往未能明确显示出卓越的疗效。我们还展示了一项最近未发表的膝骨关节炎试验的一些关键发现,以表明阿育吠陀药物与塞来昔布和氨基葡萄糖之间的等效性,并且我们推测等效性试验可能是前进的方向。试验数据也支持了阿育吠陀医学中“rasayana”的免疫调节和愈合概念。在药物研发和验证中采用现代科学工具时,我们需要解读阿育吠陀医学的逻辑,这需要大量的研究。使用后一种方法验证阿育吠陀药物可能会形成基于证据的阿育吠陀医学与现代医学的结合。此外,为了寻求更好的治疗方案,我们应该超越仅关注药物的范畴,尝试按照经典阿育吠陀医学验证全面的特定治疗方案。最后,验证一种具有卓越疗效和安全性的联合(阿育吠陀医学和现代医学)治疗方法,可能是克服目前仅使用现代药物治疗像关节炎这样的疑难病症时所面临的一些挫折的重大飞跃。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac9e/3087360/dbd3b83e87ec/JAIM-1-190-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac9e/3087360/56c1e7690503/JAIM-1-190-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac9e/3087360/dbd3b83e87ec/JAIM-1-190-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac9e/3087360/56c1e7690503/JAIM-1-190-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac9e/3087360/dbd3b83e87ec/JAIM-1-190-g002.jpg

相似文献

1
Ayurveda-modern medicine interface: A critical appraisal of studies of Ayurvedic medicines to treat osteoarthritis and rheumatoid arthritis.阿育吠陀医学与现代医学的界面:对治疗骨关节炎和类风湿关节炎的阿育吠陀药物研究的批判性评估。
J Ayurveda Integr Med. 2010 Jul;1(3):190-8. doi: 10.4103/0975-9476.72620.
2
Development of Ayurveda - Tradition to trend.阿育吠陀的发展——传统到潮流。
J Ethnopharmacol. 2017 Feb 2;197:10-24. doi: 10.1016/j.jep.2016.09.024. Epub 2016 Sep 12.
3
Ayurvedic research and methodology: Present status and future strategies.阿育吠陀研究与方法:现状与未来策略。
Ayu. 2015 Oct-Dec;36(4):364-369. doi: 10.4103/0974-8520.190699.
4
Knowledge, attitude, and practices toward ayurvedic medicine use among allopathic resident doctors: A cross-sectional study at a tertiary care hospital in India.对抗疗法住院医生使用阿育吠陀医学的知识、态度和实践:印度一家三级护理医院的横断面研究。
Perspect Clin Res. 2013 Jul;4(3):175-80. doi: 10.4103/2229-3485.115380.
5
Efficacy and safety of Ayurvedic medicines: Recommending equivalence trial design and proposing safety index.阿育吠陀药物的疗效与安全性:推荐等效性试验设计并提出安全指数。
Int J Ayurveda Res. 2010 Jul;1(3):175-80. doi: 10.4103/0974-7788.72491.
6
Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: ashwagandha.印度阿育吠陀药用植物用于治疗神经退行性疾病的科学依据:南非醉茄。
Cent Nerv Syst Agents Med Chem. 2010 Sep 1;10(3):238-46. doi: 10.2174/1871524911006030238.
7
Concept of interactions between consumable substances in Ayurveda with special reference to foods and drugs.阿育吠陀中可食用物质之间相互作用的概念,特别提及食物和药物。
Drug Metabol Drug Interact. 2013;28(3):147-52. doi: 10.1515/dmdi-2013-0014.
8
Ayurvedic medicine and arthritis.
Rheum Dis Clin North Am. 2000 Feb;26(1):133-44, x. doi: 10.1016/s0889-857x(05)70127-7.
9
Ayurvedic medicine for rheumatoid arthritis: a systematic review.阿育吠陀医学治疗类风湿性关节炎:一项系统综述。
Semin Arthritis Rheum. 2005 Apr;34(5):705-13. doi: 10.1016/j.semarthrit.2004.11.005.
10
Integrating Ayurvedic philosophy with modern technologies for drug research and development: A critical need of mechanistic insights for wider acceptability.将阿育吠陀哲学与现代技术相结合用于药物研发:为获得更广泛认可而对机理见解的迫切需求。
J Ayurveda Integr Med. 2024 Sep-Oct;15(5):100954. doi: 10.1016/j.jaim.2024.100954. Epub 2024 Oct 19.

引用本文的文献

1
Clinical Safety and Efficacy of Ayurveda Multi-Herbal Formulation in the Management of Obesity.阿育吠陀多草药配方治疗肥胖症的临床安全性与疗效
Glob Adv Integr Med Health. 2025 Jul 2;14:27536130251356447. doi: 10.1177/27536130251356447. eCollection 2025 Jan-Dec.
2
Evaluation of Yograj Guggulu, Ashwagandha Churna and Narayana Taila in management of Osteoarthritis Knee: A study in tribal dominant community.瑜伽罗阇古古卢、南非醉茄粉和那罗延油治疗膝骨关节炎的疗效评估:一项在部落主导社区开展的研究
J Ayurveda Integr Med. 2025 Apr 10;16(2):101077. doi: 10.1016/j.jaim.2024.101077.
3
A Literature Review of the Integration of Ancient Indian Mythology in Clinical Medicine: A Holistic Approach to Health and Healing.

本文引用的文献

1
Is there an urban-rural divide? Population surveys of rheumatic musculoskeletal disorders in the Pune region of India using the COPCORD Bhigwan model.是否存在城乡差异?使用COPCORD比格万模型对印度浦那地区风湿性肌肉骨骼疾病进行的人口调查。
J Rheumatol. 2009 Mar;36(3):614-22. doi: 10.3899/jrheum.080675. Epub 2009 Feb 4.
2
Second World Ayurveda Congress (Theme: Ayurveda for the Future)--Inaugural Address: Part III.第二届世界阿育吠陀大会(主题:阿育吠陀面向未来)——开幕致辞:第三部分。
Evid Based Complement Alternat Med. 2008 Dec;5(4):367-9. doi: 10.1093/ecam/nen015. Epub 2008 May 14.
3
Chondroprotective Potential of Fruit Extracts of Phyllanthus emblica in Osteoarthritis.
古代印度神话在临床医学中的整合文献综述:一种健康与治愈的整体方法
Cureus. 2024 Jul 3;16(7):e63779. doi: 10.7759/cureus.63779. eCollection 2024 Jul.
4
Assessing effects of Cannabis on various neuropathologies: A systematic review.评估大麻对各种神经病理学的影响:一项系统综述。
J Ayurveda Integr Med. 2024 May-Jun;15(3):100911. doi: 10.1016/j.jaim.2024.100911. Epub 2024 Jun 13.
5
Pathophysiology, diagnosis, and herbal medicine-based therapeutic implication of rheumatoid arthritis: an overview.类风湿关节炎的病理生理学、诊断和基于草药的治疗意义:概述。
Inflammopharmacology. 2024 Jun;32(3):1705-1720. doi: 10.1007/s10787-024-01445-8. Epub 2024 Mar 25.
6
Antidiabetic Potential of Commonly Available Fruit Plants in Bangladesh: Updates on Prospective Phytochemicals and Their Reported MoAs.孟加拉国常见水果植物的降血糖潜力:潜在植物化学物质及其报道的作用机制的最新进展。
Molecules. 2022 Dec 8;27(24):8709. doi: 10.3390/molecules27248709.
7
A Comparative Study on Clinical Evaluation of the Hypolipidemic Effects of Allium sativum, Trigonella foenum-graecum, Commiphora mukul, Picrorhiza kurroa, and Piper nigrum: A Pilot Study.大蒜、葫芦巴、没药、胡黄连和黑胡椒降血脂作用的临床评价比较研究:一项初步研究
Cureus. 2022 Jul 5;14(7):e26597. doi: 10.7759/cureus.26597. eCollection 2022 Jul.
8
Antidiabetic Phytochemicals From Medicinal Plants: Prospective Candidates for New Drug Discovery and Development.药用植物中的抗糖尿病植物化学物质:新药发现和开发的潜在候选物。
Front Endocrinol (Lausanne). 2022 Feb 24;13:800714. doi: 10.3389/fendo.2022.800714. eCollection 2022.
9
(Ker Gawl.) Haw., Seeds Oil Antidiabetic Potential Using In Vivo, In Vitro, In Situ, and Ex Vivo Approaches to Reveal Its Underlying Mechanism of Action.(Ker Gawl.) Haw.,种子油具有抗糖尿病潜力,采用体内、体外、原位和离体方法揭示其作用机制。
Molecules. 2021 Mar 17;26(6):1677. doi: 10.3390/molecules26061677.
10
Swarna Bindu Prashana-an Ancient Approach to Improve the Infant's Immunity.苏瓦尔纳宾度普拉沙那——一种提高婴儿免疫力的古老方法。
Biol Trace Elem Res. 2021 Jun;199(6):2145-2148. doi: 10.1007/s12011-020-02353-y. Epub 2020 Aug 27.
石榴叶提取物对骨关节炎的软骨保护作用。
Evid Based Complement Alternat Med. 2008 Sep;5(3):329-35. doi: 10.1093/ecam/nem030.
4
Epidemiology of rheumatic musculoskeletal disorders in the developing world.发展中国家风湿性肌肉骨骼疾病的流行病学
Best Pract Res Clin Rheumatol. 2008 Aug;22(4):583-604. doi: 10.1016/j.berh.2008.07.001.
5
A 32-week randomized, placebo-controlled clinical evaluation of RA-11, an Ayurvedic drug, on osteoarthritis of the knees.一项针对阿育吠陀药物RA - 11治疗膝骨关节炎的32周随机、安慰剂对照临床评估。
J Clin Rheumatol. 2004 Oct;10(5):236-45. doi: 10.1097/01.rhu.0000138087.47382.6d.
6
Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.氨基葡萄糖、硫酸软骨素以及二者联合用于治疗膝关节疼痛性骨关节炎。
N Engl J Med. 2006 Feb 23;354(8):795-808. doi: 10.1056/NEJMoa052771.
7
Development of therapeutics: opportunities within complementary and alternative medicine.治疗方法的发展:补充和替代医学中的机遇
Nat Rev Drug Discov. 2002 Mar;1(3):229-37. doi: 10.1038/nrd750.
8
Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial.硫酸葡萄糖胺对骨关节炎进展的长期影响:一项随机、安慰剂对照临床试验。
Lancet. 2001 Jan 27;357(9252):251-6. doi: 10.1016/S0140-6736(00)03610-2.
9
Randomized double blind trial of an ayurvedic plant derived formulation for treatment of rheumatoid arthritis.一种源自阿育吠陀植物的制剂治疗类风湿性关节炎的随机双盲试验
J Rheumatol. 2000 Jun;27(6):1365-72.
10
Ayurvedic medicine and arthritis.
Rheum Dis Clin North Am. 2000 Feb;26(1):133-44, x. doi: 10.1016/s0889-857x(05)70127-7.